The mitogen-activated extracellular signal-regulated kinase (MEK)/ERK and PI3K/AKT signaling pathways are often concurrently activated in CRC, which are associated with the progression, metastasis and drug resistance of CRC [45–47]. Here, AKT1 is linked to colorectal carcinoma.